[spacer image]
BD
[spacer image]
[spacer image]
[spacer image]
[spacer image]
[spacer image]
[spacer image]
[spacer image]
[spacer image]
[spacer image]

Healthcare-associated infections (HAIs) are a major cause of morbidity and mortality around the world. An estimated 6 million healthcare-associated infections occur each year across the United States, Europe and Japan alone.* The Centers for Disease Control and Prevention estimates there are 1.7 million infections resulting in approximately 99,000 deaths annually in the United States, making healthcare-associated infections the fourth leading cause of death.* Beyond the human toll, there is an enormous financial burden to healthcare systems worldwide. BD is committed to applying its expertise, resources and technologies toward the prevention of healthcare-associated infections worldwide.

[spacer image] News & Events

[bullet] BD Announces CE Marking of the BD GeneOhm™ VanR Molecular Test for the Rapid Detection of Vancomycin Resistance  »

[bullet] Preliminary Data from Pitt County Memorial Hospital Study Show Benefit of Active Surveillance on Reducing MRSA VAP Rates in Surgical ICU »

[bullet] BD GeneOhm™ MRSA Assay Part of Largest U.S. Study Using Universal Active Surveillance to Significantly Reduce MRSA Infection Rates  »

[bullet] BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures  »

[bullet] BD Announces CE Marking of Rapid Molecular Test to Identify Superbug from Nasal and Wound Specimens  »

[bullet] UCLH Study Demonstrates Rapid Patient Screening Could Cut MRSA Rates By Almost 40 Per Cent »

[bullet] BD Sponsors New Tool to Combat MRSA Infections in Hospitals »

[bullet] CEO Ed Ludwig Discusses Healthcare-associated Infections on CNBC (Video) »

[bullet] BD GeneOhm's Flagship Client, Evanston Northwestern Healthcare, Receives Prestigious Patient Safety Award from the NQF and the Joint Commission for its MRSA Prevention Program »

[bullet] APIC Announces MRSA Prevalence Study Results »

[bullet] BD Demonstrates Microbiology Automation Designed to Improve Laboratory Efficiency of Microbial Identification and Susceptibility Testing »

[bullet] BD Receives CE Mark Approval for Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures »

[bullet] BD Announces FDA 510(k) Submission of Two Hour Test to Identify Superbug in Patients with Positive Blood Cultures »

[bullet] BD Helping APIC to Expand its Mission in HAIs Prevention at the APIC Futures Summit (PDF) »

[bullet] "Grand Rounds" Address Impact of Antibiotic-Resistant Superbug on Healthcare Facilities (PDF) »

[bullet] Evanston Northwestern Healthcare Study Reveals Who is Most at Risk for Carrying MRSA (PDF) »

[bullet] Evanston Northwestern Healthcare Study Shows Benefit of Universal Surveillance (PDF) »

[bullet] Screening for Nasal Carriage of MRSA: Reduction of Turnaround Time and Workload by the use of BD BBL™ CHROMagar™ MRSA »

[spacer image] Learn More About...

[thumbnail image] Healthcare-Associated Infections At A Glance (PDF) »

[thumbnail image] Methicillin-Resistant Staphylococcus aureus At A Glance (PDF) »

[thumbnail image] Active Surveillance At A Glance (PDF) »

[bullet] Emergence of MRSA Timeline (PDF) »

[bullet] HAI Terminology Guide (PDF) »

[bullet] Statistical Analysis Tools for the Fisher's Exact Test and Standardized Infection Ratio (SIR) »

[bullet] BD LabO™ Winter 2007 issue features HAIs (PDF) »

[spacer image]

[spacer image] [spacer image]

[spacer image]


[spacer image] Learn about rapid molecular solutions »
[spacer image]

[spacer image]


[spacer image] Learn about BD BBL™ CHROMagar™ MRSA »
[spacer image]

[spacer image]


[spacer image] BD is proud to support APIC's "Call to Action" to eradicate MRSA »
[spacer image]

[spacer image]


[spacer image] BD 2007 Annual Report highlights the HAIs global initiative »
[spacer image]
[spacer image]

*Data on file at BD.
[spacer image]
[spacer image] [spacer image] [spacer image]
[spacer image] [spacer image] [spacer image]
[spacer image]